Growth hormone and developmental ocular function: Clinical and basic studies

Pediatric Endocrinology Reviews

Volumn 5, Issue 1, 2007, Pages 510-515

  Harvey, Stephen ^a   Baudet, Marie Laure ^a   Sanders, Esmond J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Eye; Eye development; Growth hormone; Ocular functions; Vision

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE;

ANGIOGENESIS; CELL SURVIVAL; COCKAYNE SYNDROME; DIABETIC RETINOPATHY; EYE DEVELOPMENT; EYE DISEASE; GROWTH HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; OPTIC NERVE HYPOPLASIA; POSTNATAL GROWTH; RETINA CELL; RETINITIS PIGMENTOSA; REVIEW; HYPOPHYSIS;

GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; PITUITARY GLAND;

EID: 35148842095     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Harvey S, Daughaday WH, Scanes CG. Growth Hormone, Boca Raton: CRC Press 1995
2. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: Endocr Rev 2001;22:53-74
3. Butler AA, Roith D. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 2001;63:141-164
4. Harvey S, Hull KL. Growth hormone: a paracrine growth factor? Endocrine 1997;7:261-279
5. Sanders EJ, Harvey S. Growth hormone as an early embryonic growth and differentiation factor. Anat Embryol 2004;22:1-9
6. Corbacho AM, Martinez De La Escalera, G, Clapp, C. Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 2002;173:219-238
7. Lanes R. Metabolic abnormalities in growth hormone deficiency. Pediatr Endocrinol Rev 2004;2:209-215
8. Norrelund H. Consequences of growth hormone deficiency for intermediary metabolism and effects of replacement. Front Horm Res 2005;33:103-120
9. Diaz-Casares A, Leon Y, de la Rosa EJ, Varela-Nieto I. Regulation of vertebrae sensory organ development: a scenario for growth hormone and insulin-like growth factors action. Adv Exp Med Biol 2005;567:221-242
10. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcos JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev Brain Res 1993,74:225-233
11. Harvey S, Johnson CDM, Sanders EJ. Growth hormone in neural tissues of chick embryos. J Endocrinol 2001;169:487-498
12. Harvey S, Kakebeeke M, Murphy AE, Sanders EJ. Growth hormone in the nervous system: autocrine or paracrine roles in retinal function? Can J Physiol Pharmacol 2003;81:371-384
13. Otteson D, Cirenza P, Hitchcock P. Persistent neurogenesis in the teleost retina: evidence for regulation by the growth-hormone/insulin-like growth factor-I axis. Mech Dev 2002;117:137
14. Baudet M-L, Sanders EJ, Harvey S. Retinal growth hormone in the chick embryo. Endocrinology 2003;144:5459-5468
15. Harvey S, Baudet M-L, Sanders, EJ. Growth hormone and cell survival in the neural retina: caspase dependence and independence. NeuroReport 2006 in press
16. Sanders EJ, Parker E, Harvey S. Retinal ganglion cell survival in development: mechanisms of retinal growth hormone action. Exp Eye Res 2006 in press
17. Sanders EJ, Parker E, Aramburo C, Harvey S. Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation. Exp Eye Res 2005;81:551-560
18. Rymaszewski Z, Cohen RM, Chomczynski P. Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. Proc Natl Acad Sci USA 1991;88:617-621
19. Werther GA, Haynes K, Waters MJ. Growth hormone (GH) receptors are expressed on human fetal mesenchymal tissues-identification of messenger ribonucleic acid and GH-binding protein. J Clin Endocrinol Metab 1993;76:1638-1646
20. Wilson SH, Davis Ml, Caballero S, Grant MB. Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy. Growth Horm IGF Res 2001;suppl A:S53-S59
21. Folkow B, Isaksson OP, Karlstrom G, Lever AF, Nordlander M. The importance of hypophyseal hormones for structural cardiovascular adaptation in hypertension. J Hypertens Ion Suppl 1988;6:S166-S169
22. Smith LEH, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997;276:1706-1709
23. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner Rl, Martial JA. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 1999;96:1246-1251
24. Forester JV. Shedding light on a new eye protein. Br J Ophthalmol 2004;88:602-603
25. Foos R, Kopelow S. Development of retinal vasculature in prenatal infants. Surv Ophthalmol 18:117-127
26. Roth AM. Retinal vascular development in premature infants. Am J Ophthalmol 1997;84:636-640
27. James CR, Cotlier E. Fate of insulin in the retina: an autoradiographic study. Br J Ophthalmol 1983;67:80-88
28. Modanlou HD, Gharraee Z, Hasan J, Waltzman J, Nageotte S, Beharry KDA. Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Inv Ophthalmol Vis Sci 2006;47:738-744
29. Cunha-Vas JG. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 2004;78:715-721
30. Liebner S, Gerhardt H, Wolburg H. Maturation of the blood-retina barrier in the developing pectin oculi of the chicken. Brain Res Dev Brain Res 1997;100:205-219
31. Sanders EJ, Walter MA, Parker E, Aramburo C, Harvey S. Opticin binds retinal growth hormone in the embryonic vitreous. Invest Ophthalmol Vis Sci 2003;44:5404-5409
32. Harvey S, Baudet M-L, Sander EJ. Growth hormone in brain and retina. 87th Ann Meet Endocr Soc San Diego, 2005;s25-3:36
33. Takeuchi S, Haneda M, Teshigawara K, Takahashi S. Identification of a novel GH isoform: a possible link between GH and melanocortin systems in the developing chicken eye. Endocrinology 2001;142:5158-5166
34. Harvey S, Baudet M-L, Sanders EJ. Evidence for the expression and translation of a novel growth hormone transcript in central and peripheral tissues of chick embryos. Neuropeptides 2006;40:151
35. Baudet M-L, Harvey S. Small growth hormone variant (s-cGH) in the early chick embryo. 87th Ann Meet Endocr Soc Dan Diego, p. 1-73
36. Beharry KDA, Modanlou HD, Hasan J, Gharraee Z, Abad-Santos P, Sills JH, Jan A Nageotte S, Aranda JV. Comparative effects of early postnatal Ibuprofen and Indomethacin on VEGF, IGF-I, and GH during rat ocular development. Inv Ophthalmol Vis Sci 2006;47:3036-3043
37. Harvey S, Baudet M-L, Sanders EJ. Retinal growth hormone in perinatal and adult rats. J Mol Neurosci 2006;28:257-264
38. Chanson P, Salenave S. Diagnosis and treatment of pituitary adenomas. Minerva Endocrinol 2004;29:241-275
39. Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995;126:996-999
40. Collett-Solbert PF, Liu GT, Satin-Smith M, Levitt Katz L, Moshang T Jr. Pseudopapilledema and congenital disc anomalies in growth hormone deficiency. J Pediatr Endocrinol Metab 1998;11:261-265
41. Corcuff JB, Ogor C, Kerlan V, Rougier MB, Bercovichi M, Roger P. Ocular naevus and melanoma in acromegaly. Clin Endocrinol (Oxf) 1997;47:119-121
42. Drake AJ, Lowis SP, Bouffet E, Crowne EC. Growth hormone hypersecretion in a girl with neurofibromatosis type and an optic nerve glioma: resolution following chemotherapy. Horm Res 2000;53:305-308
43. Merimee TJ. Diabetic retinopathy. A synthesis of perspectives. N Engl J Med 1990;322:978-983
44. Hattori N, Moridera K, Ishihara T, Hino M, Ikekubo K, Kurahachi H. Is growth hormone associated with diabetic retinopathy? J Diabet Comp 1993;7:12-14
45. Frystyk J. The growth hormone - 2005 revision. Horm Metab Res 2005;37:44-48
46. Sharp PS, Foley K, Vitelli F, Maneschi F, Kohner EM. Growth hormone response to hyperinsulinaemia in insulin-dependent diabetics. Comparison of patients with and without retinopathy. Diabet Med 1984;1:55-58
47. Kaneko K, Komine S, Maeda T, Ohta M, Tsushima T, Shizume K. Growth hormone responses to growth-hormone-releasing hormone and thyrotropin-releasing hormone in diabetic patients with and without retinopathy. Diabetes 1985;34:710-713
48. Merimee TJ. A follow-up study of vascular disease in growth-hormone- deficient dwarfs with diabetes. N Engl J Med 1978;298:1217-1222
49. rd, Rizza RA. The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 1994;17:422-423
50. Beck RW, Frank RN, Kraker RT, Ellis k. The effect of growth hormone receptor antagonist drug on proliferative diabetic retinopathy. Growth Hormone Antagonist for Proliferative Diabetic Retinopathy Study Group. Ophthalmology 2001;108:2266-2272
51. Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-DeHoff R, Caballero S, Estes KS. The efficacy of octreotide in the therapy of severe non-proliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care 2001;23:504-509
52. Grant MB, Caballero S. Somatostatin analogues as drug therapies for retinopathies. Drugs Today (Barc) 2002;38:783-791
53. Higgins RD, Yan Y, Schrier BK. Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 2002;74:553-559
54. Davis MI, Wilson SH, Grant MB. The therapeutic problem of proliferative diabetes retinopathy: targeting somatostatin receptors. Horm Metab Res 2001;33:295-299
55. Koller EA, Green L, Gertner JM, Bost M, Malozowski SN. Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients. J Clin Endocrinol Metab 2000;83:2380-2383
56. Okada S, Kopchick JJ. Biological effects of growth hormone and its antagonist. Trends Mol Med 2001;7:126-132
57. Hansen R, Koller EA, Malozowski S. Full remission of growth hormone (GH-induced retinopathy after GH treatment discontinuation: long-term follow-up. J Clin. Endocrinol Metab 2000;85:2627
58. Urban B, Gardziejczyk M, Urban M, Bakunowicz-Lazarczyk A. Effect of human growth hormone treatment on the eyes of patients with somatotropic pituitary insufficiency and in girls with Turner's syndrome. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2005;11:9-12
59. Blank D, Riedl M, Reitner A, Schnack C, Schernthaner G, Clodi M, Frisch H, Luger A. Growth hormone replacement therapy is not associated with retinal changes. J Clin Endocrinol Metab 2000;85:634-636
60. Zadik Z, Kowarski A. Incidence of neurosecretory dysfunction among children aged 6-14 years in Rehovot, Israel. Acta Paediatr Scand 1989;349:77-80
61. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison MJ. Utah growth study: growth standards and the prevalence of growth hormone deficiency. Pediatr 1994;125:29-35
62. Hellstrom A, Svensson E, Carlsson B, Niklasson A, Albertsson-Wikland K. Reduced retinal vascularization in children with growth hormone deficiency. J Clin Endocrinol Metab 1999;84:795-798
63. Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS. Septo-optic dysplasia and pituitary dwarfism. Lancet 1970;1:893-894
64. Kaplan SL, Grumbach MM, Hoyt WF. A syndrome of hypopituitary dwarfism, hypoplasma of optic nerves. Pediatr Res 1970;4:480-481
65. Willnow S, Kiess W, Butenandt O, Dorr HG, Enders A, Strasser-Vogel B, Egger J, Schwarz HP Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)-evaluation and follow up of 18 patients. Eur J Pediatr 1996;155:179-184
66. Nanduri VR, Stanhope R. Why is the retention of gonadotropin secretion common in children with panhypopituitarism due to septooptic dysplasia? Eur J Endocrinol 1999;140:48-50
67. Mutz I, Millner M, Borkenstein M. Optic nerve hypoplasia and growth hormone deficiency: de Morsier's syndrome. Wien Klin Wochenschr 1984;96:432-435
68. Parentin F, Tonini G, Perissutti P. Refractive evaluation in children and growth defect. Curr Eye Res 2004;28:11-15
69. Cuthbertson RA, Beck F, Senior PV, Haralambidis J, Penschow JD, Coghlan JP. Insulin-growth factor Il may play a local role in the regulation of ocular size. Development 1989;107:123-130
70. Parentin F, Perissutti P. Congenital growth hormone deficiency and eye refraction: a longitudinal study. Ophthalmologic 2005;219:226-231
71. Pivinick EK, Velagaleti GV, Wilroy RS, Smith ME, Rose SR, Tipton RE, Tharapel AT. Jacobsen syndrome: report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11 (q23125) and review of 52 cases. J Med Genet 1996;33:772-778
72. Bianchi C, Barera G, Picciotti M, Barbiano di Belgioioso G, Bellini F. Juvenile nephronophthisis associated with new skeletal abnormalities, tapetoretinal degeneration and liver fibrosis. Helv Paediar Acta 1989;43:449-455
73. Di Rocco M, Reco P, Arslanian A, Restagno G, Perfumo F, Buoncompagni A, Gattorno M, Borrone C. Retinitis pigmentosa, hypopituitarism, nephronophthisis, and mild skeletal dysplasia (RHYNS): a new syndrome? Am J Med Genet 1997;73:1-4
74. Hedera P, Gorski JL. Retinitis pigmentosa, growth hormone deficiency, and acromelic skeletal dysplasia in two brothers: possible familial RHYNS syndrome. Am J Med Gen 2001;101:142-145
75. Park SK, Chang SH, Cho SB, Baek HS, Lee DY. Cockayne syndrome: a case with hyperinsulinemia and growth hormone deficiency. J Korean Med Sci 1994;9:74-77
76. Shurka E, Laron Z. Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr J Med Sci 1975;11:352-357